The positivity for MDM2 in Enchondroma, documented for the first time in the present study, may be related to the inhibition of the p53 pathway in this group of neoplasms promoting lesion growth, but without necessarily any prognostic implications. The gene discussed is TP53; the disease is neoplasm.